CYTOKINETICS INC - 8-K Filing
Cytokinetics entered into an underwriting agreement on May 6, 2026 for a public offering of 9,859,155 shares at $71.00 per share, with an option to purchase up to 1,478,873 additional shares. The company raised approximately $760.2 million in net proceeds after underwriting discounts and expenses. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $CYTK